Abion

Abion Equity

The The Equity of Abion (203400.KQ) as of Oct 17, 2026 is 68.36 B KRW. In the previous year, The Equity was 28.13 B KRW — a change of 143.02% (higher).

Equity

68.36 BKRW

YoY

143.02%

Last updated:

In 2025, Abion's equity was 68.36 B KRW, a 143.02% increase from the 28.13 B KRW equity in the previous year.

The Abion Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
2.46 B KRW
Jan 1, 2019
-11.01 B KRW
Jan 1, 2020
-20.04 B KRW
Jan 1, 2021
32.10 B KRW
Jan 1, 2022
15.10 B KRW
Jan 1, 2023
9.98 B KRW
Jan 1, 2024
28.13 B KRW
Jan 1, 2025
68.36 B KRW
The Abion Equity history
YEAREquityYoY
68.36 BKRW+143.02%
28.13 BKRW+181.88%
9.98 BKRW-33.91%
15.10 BKRW-52.96%
32.10 BKRW-260.21%
-20.04 BKRW+81.90%
-11.01 BKRW-547.97%
2.46 BKRW-15.42%
2.91 BKRW-45.80%
5.36 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Abion Stock analysis

What does Abion do? Abion Inc, headquartered in Seoul, South Korea, operates in the Health Care sector, specifically within Biotechnology. The company develops biopharmaceuticals for treating incurable diseases and is listed on the stock market since July 21, 2014. Abion's business segments include product development and sales of diagnostic and research reagents, CRO services such as histopathology and molecular genetic analysis, and R&D for protein, nucleic acid, and antibody therapeutics. Abion is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Abion's Equity

Abion's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Abion's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Abion's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Abion's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Abion’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Abion stock

The Equity of Abion is 68.36 B KRW in 2025.

The Equity of Abion changed from 28.13 B KRW to 68.36 B KRW, representing a 143.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Abion since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Abion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Abion

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Abion